These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9321868)

  • 1. Central opiate mu-receptor-mediated suppression of tissue protein synthesis.
    Hashiguchi Y; Molina PE; Dorton S; McNurlan MA; Garlick PJ; Reddy D; Abumrad NN
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R920-7. PubMed ID: 9321868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress.
    Marson L; Kiritsy-Roy JA; Van Loon GR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R901-8. PubMed ID: 2552846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic opioid mu-receptors regulate discrete hemodynamic functions in the conscious rat.
    Sirén AL; Feuerstein G
    Neuropharmacology; 1991 Feb; 30(2):143-52. PubMed ID: 1851544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
    Gunion MW; Rosenthal MJ; Morley JE; Miller S; Zib B; Butler B; Moore RD
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R70-81. PubMed ID: 1677542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses.
    Kiritsy-Roy JA; Appel NM; Bobbitt FG; Van Loon GR
    J Pharmacol Exp Ther; 1986 Dec; 239(3):814-22. PubMed ID: 3025420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effects of morphine and morphine-6-glucuronide on tissue protein synthesis.
    Hashiguchi Y; Molina PE; Preedy VR; Sugden PH; McNurlan MA; Garlick PJ; Abumrad NN
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R619-25. PubMed ID: 8853383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors.
    Szeto HH; Zhu YS; Cai LQ
    Am J Physiol; 1990 Jun; 258(6 Pt 2):R1453-8. PubMed ID: 2163223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain sites involved in mu-opioid receptor-mediated actions: a 2-deoxyglucose study.
    Fabian I; Ableitner A
    Brain Res; 1995 Oct; 697(1-2):205-15. PubMed ID: 8593578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAGO ([D-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Brain Res; 1991 Aug; 557(1-2):77-82. PubMed ID: 1660758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. antinociceptive properties of [D-Ala2, NMPhe4, Gly-ol]-enkephalin (DAGO) in tests of acute and tonic pain in mice.
    Mulvaney SA; Sheldon RJ; Cowan A; Porreca F
    Proc West Pharmacol Soc; 1988; 31():285-6. PubMed ID: 3211917
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the suppression of luteinizing hormone release due to activation of medial preoptic-anterior hypothalamic area mu-opioid receptors.
    Smith MJ; Gallo RV
    Brain Res Bull; 1997; 42(1):1-7. PubMed ID: 8978929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways.
    Hassen AH; Feuerstein G
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H156-62. PubMed ID: 3028161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis.
    Swain MG
    Hepatology; 1994 Sep; 20(3):700-5. PubMed ID: 8076927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of the role of CCK in the opioid modulation of the motility of the gastrointestinal tract in sheep.
    Kania BF; Brikas P; Buéno L; Fioramonti J; Zaremba-Rutkowska M
    J Vet Pharmacol Ther; 1999 Apr; 22(2):153-60. PubMed ID: 10372600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.